John Mellors
University of Pittsburgh, USA
Scientific Committee:
Lee Bacheler
Virco Lab, Inc., USA
Nick Cammack
Roche Palo Alto, USA
François Clavel
Inserm U552, France
Bonaventura Clotet
Fundacio IRSI Caixa, Spain
John Coffin
National Cancer Institute-Frederick,
USA
Dominique Costagliola
INSERM 0214, France
Richard D'Aquila
Vanderbilt University Medical Center,
USA
Victor De Gruttola
Harvard School of Public Health, USA
John Erickson
Sequoia Pharmaceuticals, USA
Robert Grant
Gladstone/UCSF, USA
Michael Greenberg
Trimeris, Inc, USA
Richard Harrigan
BC Centre For Excellence in HIV/AIDS, Canada
Daria Hazuda
Merck Research Laboratories, USA
Nicholas Hellmann
Roche Molecular Systems, Inc., USA
Dale Kempf
Abbott Laboratories, USA
Daniel Kuritzkes
Brigham and Women's Hospital, USA
Randall Lanier
GlaxoSmithKline, USA
Susan Little
University of California, San Diego, USA
Douglas Mayers
Boehringer Ingelheim Pharmaceuticals,
Inc, USA
Michael Miller
Gilead Sciences, USA
Michael Parniak
University of Pittsburgh, USA
Luc Perrin
Geneva University Hospital, Switzerland
Rick Pesano
Pfizer Global Research and Development,
USA
Christos Petropoulos
ViroLogic, Inc, USA
Deenan Pillay
Royal Free and University College Medical School, UK
Jonathan Schapiro
Stanford University, USA
Raymond Schinazi
Emory University/VA Medical Center,
USA
Mark Wainberg
McGill University AIDS Centre, Canada
Rainer Ziermann
Bayer Healthcare Diagnostics, USA
